[{"address1": "Level 10", "address2": "Tower 11 Avenue 5, No. 8 Jalan Kerinchi", "city": "Kuala Lumpur", "zip": "592000", "country": "Malaysia", "phone": "60 9 08517 7330", "website": "https://www.cyclacel.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Sing Ee Wong", "age": 43, "title": "Chairman, CEO & President", "yearBorn": 1981, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Cu Seng Kiu", "age": 34, "title": "Executive Director, CFO & Secretary", "yearBorn": 1990, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gill  Christie", "age": 67, "title": "Director of Human Resources", "yearBorn": 1957, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Grace  Kim", "title": "Investor Relations Executive", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.89, "open": 8.91, "dayLow": 7.825, "dayHigh": 9.4, "regularMarketPreviousClose": 8.89, "regularMarketOpen": 8.91, "regularMarketDayLow": 7.825, "regularMarketDayHigh": 9.4, "payoutRatio": 0.0, "trailingPE": 0.18402778, "forwardPE": -3.9949749, "volume": 205747, "regularMarketVolume": 205747, "averageVolume": 1887420, "averageVolume10days": 323890, "averageDailyVolume10Day": 323890, "bid": 0.0, "ask": 7.89, "bidSize": 0, "askSize": 1, "marketCap": 12627303, "fiftyTwoWeekLow": 3.08, "fiftyTwoWeekHigh": 597.6, "priceToSalesTrailing12Months": 1262.7303, "fiftyDayAverage": 7.7356, "twoHundredDayAverage": 59.72365, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 6426931, "profitMargins": 0.0, "floatShares": 264528, "sharesOutstanding": 1588340, "sharesShort": 101016, "sharesShortPriorMonth": 1309, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0636, "heldPercentInsiders": 0.51227003, "heldPercentInstitutions": 0.01382, "shortRatio": 0.02, "shortPercentOfFloat": 0.1299, "impliedSharesOutstanding": 1588340, "bookValue": 2.7, "priceToBook": 2.9444444, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -6408000, "trailingEps": 43.2, "forwardEps": -1.99, "lastSplitFactor": "1:15", "lastSplitDate": 1751846400, "enterpriseToRevenue": 642.693, "enterpriseToEbitda": -0.621, "52WeekChange": -0.97284836, "SandP52WeekChange": 0.15005577, "lastDividendValue": 0.15, "lastDividendDate": 1745884800, "quoteType": "EQUITY", "currentPrice": 7.95, "recommendationKey": "none", "totalCash": 4275000, "totalCashPerShare": 3.179, "ebitda": -10353000, "totalDebt": 10000, "quickRatio": 5.625, "currentRatio": 5.767, "totalRevenue": 10000, "debtToEquity": 0.275, "revenuePerShare": 0.007, "returnOnAssets": -1.0283101, "returnOnEquity": -2.7680302, "grossProfits": 10000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -1035.8, "financialCurrency": "USD", "symbol": "CYCC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1755302025, "regularMarketTime": 1755288001, "exchange": "NCM", "marketState": "CLOSED", "shortName": "Cyclacel Pharmaceuticals, Inc.", "longName": "Cyclacel Pharmaceuticals, Inc.", "postMarketChangePercent": 0.880511, "postMarketPrice": 8.02, "postMarketChange": 0.0700006, "regularMarketChange": -0.940001, "regularMarketDayRange": "7.825 - 9.4", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1887420, "fiftyTwoWeekLowChange": 4.87, "fiftyTwoWeekLowChangePercent": 1.5811689, "fiftyTwoWeekRange": "3.08 - 597.6", "fiftyTwoWeekHighChange": -589.64996, "fiftyTwoWeekHighChangePercent": -0.9866968, "fiftyTwoWeekChangePercent": -97.284836, "dividendDate": 1746057600, "earningsTimestampStart": 1754996340, "earningsTimestampEnd": 1755518400, "earningsCallTimestampStart": 1723667400, "earningsCallTimestampEnd": 1723667400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 43.2, "epsForward": -1.99, "fiftyDayAverageChange": 0.21439981, "fiftyDayAverageChangePercent": 0.02771599, "twoHundredDayAverageChange": -51.77365, "twoHundredDayAverageChangePercent": -0.8668869, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "messageBoardId": "finmb_125004", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -10.5737, "regularMarketPrice": 7.95, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1079447400000, "cryptoTradeable": false, "displayName": "Cyclacel Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]